Edition:
India

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

38.90USD
19 Jan 2018
Change (% chg)

$0.07 (+0.18%)
Prev Close
$38.83
Open
$38.79
Day's High
$39.15
Day's Low
$38.71
Volume
82,623
Avg. Vol
163,984
52-wk High
$40.62
52-wk Low
$15.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
FY 2016 Dec '16 0.00 -0.551
Sep '16 0.00 -0.526
Jun '16 0.00 -0.434
Mar '16 0.00 -0.372
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 5 0.00 0.00 0.00 --
Quarter Ending Jun-18 5 0.00 0.00 0.00 --
Year Ending Dec-18 7 0.00 0.00 0.00 20.19
Earnings (per share)
Quarter Ending Mar-18 6 -0.74 -0.59 -0.89 --
Quarter Ending Jun-18 6 -0.75 -0.60 -0.89 --
Year Ending Dec-18 7 -3.00 -2.33 -3.56 -2.54
LT Growth Rate (%) 1 34.60 34.60 34.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.98 46.03
P/E Low - Last 5 Yrs. -- 23.80 24.39
Beta -- 0.90 0.89
Price to Sales (TTM) -- 3.98 5.45
Price to Book (MRQ) 5.40 4.82 5.38
Price to Tangible Book (MRQ) 5.41 5.57 6.89
Price to Cash Flow (TTM) -- 23.02 23.43
% Owned Institutions 85.47 1.23 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.35 5.23
Payout Ratio(TTM) -- 45.67 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.59 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.69 5.44
Sales - 5 Yr. Growth Rate -- 10.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 16.23 19.33
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 13.45 2.88 2.97
LT Debt to Equity (MRQ) 0.00 9.81 12.10
Total Debt to Equity (MRQ) 0.00 13.80 16.38
Interest Coverage (TTM) -- 36.25 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.13 54.76
Gross Margin - 5 Yr. Avg. -- 52.41 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.54 15.33
Operating Margin (TTM) -- 14.40 7.60
Operating Margin - 5 Yr. Avg. -- 14.46 10.79
Pre-Tax Margin (TTM) -- 14.82 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 14.77 11.19
Net Profit Margin (TTM) -- 11.09 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.11 7.50
Effective Tax Rate (TTM) -- 23.16 23.05
Effective Tax Rate - 5 Yr. Avg. -- 23.40 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 948,195,516 855,725,045
Net Income/Employee (TTM) -1,529,406 111,561,295 100,665,187
Receivable Turnover (TTM) -- 5.61 5.76
Inventory Turnover (TTM) -- 2.57 3.34
Asset Turnover (TTM) 0.00 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 11.41 10.97
Return on Assets - 5 Yr. Avg. -- 12.98 12.39
Return on Investment (TTM) -50.47 14.84 14.40
Return on Investment - 5 Yr. Avg. -- 16.97 16.20
Return on Equity (TTM) -50.82 16.32 16.09
Return on Equity - 5 Yr. Avg. -- 18.05 17.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 80 25
13 Week 22.10 16.15 89 36
26 Week 26.67 17.04 88 31
52 Week 53.60 30.19 85 12
YTD 24.01 8.91 75 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 86.59%
# of Holders: 149
Total Shares Held: 44,043,611
3 Mo. Net Change: 432,003
# New Positions: 7
# Closed Positions: 2
# Increased Positions: 16
# Reduced Positions: 6
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.